Q32 Bio (QTTB) Cash from Investing Activities Growth (3y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.00% |
| Dec 31, 2024 | -25.99% |
| Sep 30, 2024 | 30.01% |
| Jun 30, 2024 | 39.59% |
| Mar 31, 2024 | 26.02% |
| Sep 30, 2023 | -25.99% |
| Jun 30, 2023 | -97.32% |
| Mar 31, 2023 | -25.99% |
| Dec 31, 2022 | 42.58% |
| Sep 30, 2022 | -101.96% |
| Jun 30, 2022 | -2.60% |
| Mar 31, 2022 | 104.55% |
| Dec 31, 2021 | 62.36% |
| Sep 30, 2021 | 28.06% |
| Jun 30, 2021 | 47.21% |
| Mar 31, 2021 | -145.72% |
| Dec 31, 2020 | 77.14% |
| Sep 30, 2020 | 408.75% |
| Jun 30, 2020 | 381.87% |
| Mar 31, 2020 | 416.19% |